Keertan Dheda
Dheda, Keertan 1969-
VIAF ID: 22153893603102290470 (Personal)
Permalink: http://viaf.org/viaf/22153893603102290470
Preferred Forms
-
100 1 _
‡a
Dheda, Keertan
‡d
1969-
-
100 0 _
‡a
Keertan Dheda
4xx's: Alternate Name Forms (3)
Works
| Title | Sources |
|---|---|
| HIV associated Lymphocytic Interstitial Pneumonia: a clinical, histological and radiographic study from an HIV endemic resource-poor setting |
|
| HIV self-testing strategy: the middle road |
|
| Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection |
|
| ICU-associated Acinetobacter baumannii colonisation/infection in a high HIV-prevalence resource-poor setting |
|
| The identification of tuberculosis biomarkers in human urine samples |
|
| Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy : pathogenesis, clinical manifestations and management |
|
| Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not. |
|
| The immunology of tuberculosis: from bench to bedside |
|
| Impact of correcting the lymphocyte count to improve the sensitivity of TB antigen-specific peripheral blood-based quantitative T cell assays (T-SPOT.(®)TB and QFT-GIT). |
|
| Impact of nicotine replacement therapy as an adjunct to anti-tuberculosis treatment and behaviour change counselling in newly diagnosed pulmonary tuberculosis patients: an open-label, randomised controlled trial. |
|
| Impact of the GeneXpert MTB/RIF Technology on Tuberculosis Control |
|
| In vivo and in vitro studies of a novel cytokine, interleukin 4delta2, in pulmonary tuberculosis |
|
| In Vivo Molecular Dissection of the Effects of HIV-1 in Active Tuberculosis |
|
| Increased production of IL-4 and IL-12p40 from bronchoalveolar lavage cells are biomarkers of Mycobacterium tuberculosis in the sputum |
|
| Lack of cross-toxicity between isoniazid and ethionamide in severe cutaneous adverse drug reactions: a series of 25 consecutive confirmed cases |
|
| Latent Tuberculosis Infection-associated Immunodiagnostic Test Responses as Biomarkers of Incipient Tuberculosis: Fruitful or Futile? |
|
| Lethal interaction: the colliding epidemics of tobacco and tuberculosis |
|
| Lichenoid drug reaction to antituberculosis drugs treated through with topical steroids and phototherapy |
|
| Lifestyle, attitudes and needs of uncured XDR-TB patients living in the communities of South Africa: a qualitative study |
|
| Making HIV testing work at the point of care in South Africa: a qualitative study of diagnostic practices |
|
| The Multi-Step TB Diagnostic Cascade: More than Meets the Eye. |
|
| Myobacterium tuberculosis induces selective up-regulation of TLRs in the mononuclear leukocytes of patients with active pulmonary tuberculosis |
|
| New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance |
|
| Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy |
|
| Pan-tuberculosis regimens: an argument against. |
|
| The pathogen recognition sensor, NOD2, is variably expressed in patients with pulmonary tuberculosis |
|
| Performance of the TB-LAMP diagnostic assay in reference laboratories: Results from a multicentre study |
|
| Peripheral T cell interferon-gamma responses and latent tuberculosis |
|
| Predictors of discordant latent tuberculosis infection test results amongst South African health care workers |
|
| Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis |
|
| Psychological distress and its relationship with non-adherence to TB treatment: a multicentre study |
|
| Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study |
|
| Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study |
|
| Rationalizing use of fluoroquinolones and pyrazinamide in the battle against multidrug-resistant tuberculosis |
|
| Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB? |
|
| Recombination in pe/ppe genes contributes to genetic variation in Mycobacterium tuberculosis lineages |
|
| Recommendations for the management of idiopathic pulmonary fibrosis in South Africa: a position statement of the South African Thoracic Society |
|
| Recommendations for the use of bronchial thermoplasty in the management of severe asthma |
|
| Regulatory T cells attenuate mycobacterial stasis in alveolar and blood-derived macrophages from patients with tuberculosis. |
|
| Regulatory T Cells Subvert Mycobacterial Containment in Patients Failing Extensively Drug-resistant TB Treatment |
|
| Relationship between chemokine receptor expression, chemokine levels and HIV-1 replication in the lungs of persons exposed to Mycobacterium tuberculosis |
|
| Removing the bottleneck in whole genome sequencing of Mycobacterium tuberculosis for rapid drug resistance analysis: a call to action |
|
| Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa |
|
| Revising the definition of extensively drug-resistant tuberculosis |
|
| Sanatoria for drug-resistant tuberculosis: an outdated response – Authors' reply |
|
| Scoring systems using chest radiographic features for the diagnosis of pulmonary tuberculosis in adults: a systematic review |
|
| Selection and application of ssDNA aptamers to detect active TB from sputum samples |
|
| Sensitivity of C-Tb: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection |
|
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials |
|
| Smoking is not beneficial for tuberculosis |
|
| South African guideline for the management of community-acquired pneumonia in adults |
|
| South African tobacco smoking cessation clinical practice guideline |
|
| Sputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settings |
|
| The stability of mRNA encoding IL-4 is increased in pulmonary tuberculosis, while stability of mRNA encoding the antagonistic splice variant, IL-4δ2, is not |
|
| A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis |
|
| The Sterilizing Effect of Intermittent Tedizolid for Pulmonary Tuberculosis |
|
| Supervised and unsupervised self-testing for HIV in high- and low-risk populations: a systematic review |
|
| T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward |
|
| TB diagnostic tests: how do we figure out their costs? |
|
| Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing |
|
| Therapeutic Trial of Rifabutin After Rifampicin-Associated DRESS Syndrome in Tuberculosis-Human Immunodeficiency Virus Coinfected Patients |
|
| Time for the Global Rollout of Endoscopic Lung Volume Reduction |
|
| Time to revise WHO-recommended definitions of MDR-TB treatment outcomes. |
|
| Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis |
|
| TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment |
|
| Tuberculosis and Poncet's disease: the many faces of an old enemy |
|
| Tuberculosis in association with HIV/AIDS emerges as a major nonobstetric cause of maternal mortality in Sub-Saharan Africa |
|
| Tuberculous meningitis is associated with higher cerebrospinal HIV-1 viral loads compared to other HIV-1-associated meningitides |
|
| Type 2 cytokines in respiratory syncytial virus bronchiolitis |
|
| Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments |
|
| The use of an automated quantitative polymerase chain reaction (Xpert MTB/RIF) to predict the sputum smear status of tuberculosis patients |
|
| Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review |
|
| Utility of a novel lipoarabinomannan assay for the diagnosis of tuberculous meningitis in a resource-poor high-HIV prevalence setting |
|
| Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis |
|
| Validation of housekeeping genes for normalizing RNA expression in real-time PCR. |
|
| The variability and reproducibility of whole genome sequencing technology for detecting resistance to anti-tuberculous drugs |
|
| Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection |
|
| What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa? |
|
| Will an unsupervised self-testing strategy for HIV work in health care workers of South Africa? A cross sectional pilot feasibility study |
|
| Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review |
|
| World TB Day 2010 - New innovations are required for enhancing the global fight against Tuberculosis: the ‘Captain of all these men of death’ |
|
| Xpert MTB/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppression |
|
